Danielle Hartle
Medical · Phoenix, AZNPI 1073795530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 28.8% of the total. Reporting peaked in 2021 at $2,417 and has fallen 50.6% since, to $1,195 in 2025. Among medical clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- Pfizer$548
- Lilly USA, LLC$546
- Johnson & Johnson$443
- Novartis$435
- plus $3K from 24 others
What the payments were for
- Food & beverage$7,978100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 133 | $2,296 |
| Amgen(2 entities) | 63 | $1,154 |
| Pfizer | 33 | $548 |
| Lilly USA, LLC | 34 | $546 |
| Johnson & Johnson(2 entities) | 32 | $443 |
| Novartis | 23 | $435 |
| UCB, Inc. | 13 | $418 |
| AstraZeneca(2 entities) | 8 | $302 |
| GSK | 19 | $301 |
| Sanofi | 9 | $213 |
| Boehringer Ingelheim | 8 | $209 |
| E.r. Squibb & Sons, L.L.C. | 10 | $209 |
| Radius Health, Inc. | 7 | $172 |
| Shockwave Medical, Inc | 1 | $165 |
| Aurinia Pharma U.S., Inc. | 6 | $125 |
| Fresenius Kabi USA, LLC | 3 | $81 |
| Sanofi Pasteur Inc. | 2 | $56 |
| Organon | 3 | $53 |
| Sobi, Inc | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Neurelis, Inc. | 1 | $19 |
| Merck | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| Viiv Healthcare Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,978 in reported general payments places this provider in the 90th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 12 | $86,159 |
| Hydroxychloroquine Sulfate | 257 | $10,085 |
| MethotrexateMethotrexate Sodium | 207 | $4,976 |
| Leflunomide | 30 | $2,160 |
| Colchicine | 15 | $1,238 |
| Prednisone | 178 | $1,160 |
| Tramadol Hcl | 124 | $937 |
| Duloxetine Hcl | 35 | $879 |
| Gabapentin | 35 | $607 |
| Pregabalin | 39 | $576 |
| Sulfasalazine | 41 | $527 |
| Alendronate Sodium | 50 | $437 |
| Baclofen | 23 | $318 |
| Folic Acid | 33 | $304 |
| Allopurinol | 12 | $257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Colchicine | $15 | $1,23815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 748 medical providers in Arizona.
Other medical in Phoenix
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
- Jennifer KiserPhoenix$53K
- Lakeisha ColterPhoenix$48K
- Amy IngersollPhoenix$42K
- Ty NielsonPhoenix$18K
- Brittany SilvermanPhoenix$16K
- John RimerPhoenix$15K
- Rana AoufePhoenix$14K
- Adam SchwartzPhoenix$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.